160 related articles for article (PubMed ID: 25055067)
1. Incidence of postoperative dyspepsia is not associated with prophylactic use of drugs.
Tsuchie SY; Nani FS; Vieira JE
Sao Paulo Med J; 2014; 132(4):219-23. PubMed ID: 25055067
[TBL] [Abstract][Full Text] [Related]
2. [Evidence based treatment strategy for dyspeptic symptoms].
Miwa H; Oshima T; Tomita T
Nihon Shokakibyo Gakkai Zasshi; 2007 Nov; 104(11):1594-600. PubMed ID: 17984607
[No Abstract] [Full Text] [Related]
3. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
[TBL] [Abstract][Full Text] [Related]
4. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
5. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
9. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
[TBL] [Abstract][Full Text] [Related]
10. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
Qvigstad G; Arnestad JS; Brenna E; Waldum HL
Scand J Gastroenterol; 1998 Dec; 33(12):1244-8. PubMed ID: 9930386
[TBL] [Abstract][Full Text] [Related]
11. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
12. Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole.
Savarino V; Bisso G; Pivari M; Zentilin P; Bilardi C; Dulbecco P; Mele MR; Tracci D; Vigneri S
Aliment Pharmacol Ther; 2000 Mar; 14(3):291-7. PubMed ID: 10735921
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
14. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
16. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
Kaplan-Machlis B; Spiegler GE; Zodet MW; Revicki DA
Arch Fam Med; 2000 Jul; 9(7):624-30. PubMed ID: 10910310
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease.
Lauritsen K; Rutgersson K; Bolling E; Brunner G; Eriksson S; Galmiche JP; Walan A; Archambault AP; Gudjónsson H; Bailey RJ; Bianchi Porro G; Frison L; Havu N; Thompson AB
Can J Gastroenterol; 1999 Dec; 13(10):806-13. PubMed ID: 10625320
[TBL] [Abstract][Full Text] [Related]
20. Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.
Nayyar AK; Royston C; Bardhan KD
Dig Liver Dis; 2003 Mar; 35(3):143-50. PubMed ID: 12779067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
